基于线粒体功能障碍探讨从“玄府”论治糖尿病肾病
Exploring the Treatment of Diabetic Nephropathy Based on Mitochondrial Dysfunction from the Perspective of “Xuanfu” Theory
DOI: 10.12677/acm.2025.15102821, PDF,   
作者: 刘 旺:黑龙江中医药大学研究生院,黑龙江 哈尔滨;栾仲秋*:黑龙江中医药大学附属第一医院肾病一科,黑龙江 哈尔滨
关键词: 线粒体玄府糖尿病肾病中医药治疗Mitochondria Xuanfu Diabetic Nephropathy Traditional Chinese Medicine Treatment
摘要: 糖尿病肾病(Diabetic Kidney Disease, DKD)作为糖尿病最常见的微血管并发症之一,已成为终末期肾脏病的主要原因,其发病机制复杂,涉及代谢紊乱、线粒体功能障碍、氧化应激、炎症反应等多个环节,其中线粒体功能障碍被认为是驱动DKD进展的核心病理机制,线粒体氧化应激、生物合成紊乱、融合与分裂异常、过度自噬等都会导致线粒体功能障碍,进而导致DKD进展。“玄府”是中医理论的重要组成部分,具有流通气液、渗灌血气、转运神机的生理功能。DKD核心病机总属阴虚为本、燥热为标,又与“风”密切相关,病久阴阳两虚,湿痰瘀内生,致使玄府闭塞不通,功能失调,开泄太过,治疗应以通玄、补玄、固玄为法,改善线粒体功能,进而延缓DKD进展。
Abstract: Diabetic kidney disease (DKD) as one of the most common microvascular complications of diabetes, has become the main cause of end stage renal disease (ESRD). Its pathogenesis is complex, involving multiple pathways such as metabolic disorders, mitochondrial dysfunction, oxidative stress, and inflammatory responses. Among these, mitochondrial dysfunction is considered the core pathological mechanism driving the progression of DKD. Mitochondrial oxidative stress, biosynthetic disorders, abnormalities in fusion and fission, and excessive autophagy can all lead to mitochondrial dysfunction, which in turn drives the progression of DKD. The “Xuanfu theory” is an important part of traditional Chinese medicine theory and has physiological functions such as circulating qi and fluids, permeating blood and qi, and transporting spiritual energy. The core pathogenesis of DKD is fundamentally characterized by yin deficiency and superficially by dry heat, and is closely related to “wind”. DKD is characterized by long-term deficiency of both yin and yang, leading to the accumulation of dampness, phlegm, and stasis internally. This results in the obstruction of the Xuanfu, dysfunction, and excessive dispersion. Treatment should focus on unblocking, tonifying, and consolidating the Xuanfu to improve mitochondrial function and thereby slow the progression of DKD.
文章引用:刘旺, 栾仲秋. 基于线粒体功能障碍探讨从“玄府”论治糖尿病肾病[J]. 临床医学进展, 2025, 15(10): 794-802. https://doi.org/10.12677/acm.2025.15102821

参考文献

[1] Shaw, J.E., Sicree, R.A. and Zimmet, P.Z. (2010) Global Estimates of the Prevalence of Diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87, 4-14. [Google Scholar] [CrossRef] [PubMed]
[2] Cho, N.H., Shaw, J.E., Karuranga, S., Huang, Y., da Rocha Fernandes, J.D., Ohlrogge, A.W., et al. (2018) IDF Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045. Diabetes Research and Clinical Practice, 138, 271-281. [Google Scholar] [CrossRef] [PubMed]
[3] Umanath, K. and Lewis, J.B. (2018) Update on Diabetic Nephropathy: Core Curriculum 2018. American Journal of Kidney Diseases, 71, 884-895. [Google Scholar] [CrossRef] [PubMed]
[4] 崇小敏, 李智滨. 中西医治疗糖尿病肾病研究进展[J]. 光明中医, 2025, 40(5): 996-999.
[5] 王明杰. “玄府”论[J]. 成都中医学院学报, 1985(3): 1-4.
[6] 邹东浩, 戴铭. 基于“玄府-气液-肾络”理论论治慢性肾小球肾炎[J/OL]. 实用中医内科杂志, 1-4.
https://link.cnki.net/urlid/21.1187.R.20250214.1407.010, 2025-08-03.
[7] 黄奡, 张颖, 张兰. 张兰教授基于肾玄府理论论治糖尿病肾病[J]. 辽宁中医药大学学报, 2023, 25(7): 122-125.
[8] 常富业, 王永炎, 高颖, 等. 玄府概念诠释(四)——玄府为气升降出入之门户[J]. 北京中医药大学学报, 2005(3): 10-12.
[9] 常富业, 杨宝琴, 王永炎, 等. 玄府概念诠释(五)——玄府流通气液功能的探讨[J]. 北京中医药大学学报, 2005(4): 13-15.
[10] 叶汝萍, 胡镜清, 方锐, 等. 论“玄府” [J]. 中华中医药杂志, 2017, 32(4): 1465-1468.
[11] 常富业, 王永炎, 高颖, 等. 玄府概念诠释(六)——玄府为神机运转之道路门户[J]. 北京中医药大学学报, 2005(5): 12-13.
[12] 吴以岭. 气络论[M]. 北京: 科学技术文献出版社, 2018: 10-18+175-197.
[13] 沈双, 魏聪, 常丽萍. “孙络-玄府”论治糖尿病肾病[J]. 疑难病杂志, 2022, 21(6): 638-641.
[14] 艾思南, 王珍, 王耀献. 基于玄府理论探讨中医治疗肾脏疾病[J]. 环球中医药, 2024, 17(1): 106-109.
[15] 刘尚建, 王翚, 王耀献, 等. “肾络微型癥瘕”理论初探[J]. 中国中医基础医学杂志, 2009, 15(9): 649-650.
[16] Sheng, J., Li, H., Dai, Q., Lu, C., Xu, M., Zhang, J., et al. (2018) NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy. Cellular Physiology and Biochemistry, 48, 1675-1693. [Google Scholar] [CrossRef] [PubMed]
[17] 李岚, 沈清. 线粒体功能障碍在糖尿病肾病发生发展中的作用、作用机制及药物治疗研究进展[J]. 山东医药, 2022, 62(33): 111-115.
[18] Madsen-Bouterse, S.A., Zhong, Q., Mohammad, G., Ho, Y. and Kowluru, R.A. (2010) Oxidative Damage of Mitochondrial DNA in Diabetes and Its Protection by Manganese Superoxide Dismutase. Free Radical Research, 44, 313-321. [Google Scholar] [CrossRef] [PubMed]
[19] Ruiz, S., Pergola, P.E., Zager, R.A. and Vaziri, N.D. (2013) Targeting the Transcription Factor Nrf2 to Ameliorate Oxidative Stress and Inflammation in Chronic Kidney Disease. Kidney International, 83, 1029-1041. [Google Scholar] [CrossRef] [PubMed]
[20] Galvan, D.L., Green, N.H. and Danesh, F.R. (2017) The Hallmarks of Mitochondrial Dysfunction in Chronic Kidney Disease. Kidney International, 92, 1051-1057. [Google Scholar] [CrossRef] [PubMed]
[21] 骆静, 方丽, 袁琦, 等. 线粒体功能障碍在糖尿病肾病进展的作用[J]. 现代生物医学进展, 2015, 15(20): 3964-3967.
[22] 鲁伶旭, 徐莉, 范秋灵, 汪旭, 曹旭, 王力守. 晚期糖基化终末产物诱导肾小球系膜细胞线粒体途径凋亡[J]. 中华肾脏病杂志, 2018, 34(2): 122-129.
[23] Sun, S., Yang, S., Cheng, Y., Fang, T., Qu, J., Tian, L., et al. (2024) Jinlida Granules Alleviate Podocyte Apoptosis and Mitochondrial Dysfunction via the AMPK/PGC-1α Pathway in Diabetic Nephropathy. International Journal of Molecular Medicine, 55, Article No. 26. [Google Scholar] [CrossRef] [PubMed]
[24] 钟睿, 赵丹麦, 王晓天, 等. 中医药调控线粒体动力学治疗糖尿病肾病[J/OL]. 中医学报, 1-12.
https://link.cnki.net/urlid/41.1411.R.20250225.1900.058, 2025-08-03.
[25] Cao, Y., Chen, Z., Hu, J., Feng, J., Zhu, Z., Fan, Y., et al. (2021) Mfn2 Regulates High Glucose-Induced MAMs Dysfunction and Apoptosis in Podocytes via PERK Pathway. Frontiers in Cell and Developmental Biology, 9, Article 769213. [Google Scholar] [CrossRef] [PubMed]
[26] Luo, A., Wang, R., Gong, J., Wang, S., Yun, C., Chen, Z., et al. (2025) Syntaxin 17 Translocation Mediated Mitophagy Switching Drives Hyperglycemia-Induced Vascular Injury. Advanced Science, 12, e2414960. [Google Scholar] [CrossRef] [PubMed]
[27] Chen, Z., Ma, Y., Yang, Q., Hu, J., Feng, J., Liang, W., et al. (2020) AKAP1 Mediates High Glucose-Induced Mitochondrial Fission through the Phosphorylation of Drp1 in Podocytes. Journal of Cellular Physiology, 235, 7433-7448. [Google Scholar] [CrossRef] [PubMed]
[28] 李宇轩, 汪吴娇, 李鹏, 等. 基于线粒体功能探讨从“玄府-络脉-脏腑”论治心力衰竭[J]. 中医杂志, 2024, 65(13): 1346-1352.
[29] 张梨, 吴梦竹, 周冬祺, 等. 基于线粒体功能的玄府郁闭络脉受损与糖尿病微循环障碍的发生发展关系探讨[J]. 时珍国医国药, 2021, 32(5): 1188-1191.
[30] 艾思南, 王耀献. 肾病“治玄三步法”探微[J]. 中华中医药杂志, 2024, 39(9): 4538-4543.
[31] 罗再琼, 黄淑芬, 王明杰. 论风药的活血作用及其特点[J]. 中医杂志, 2000(8): 453-454.
[32] 罗仁书, 何治勇. 川芎有效成分药理作用的研究进展[J]. 中国医院用药评价与分析, 2018, 18(9): 1294-1296.
[33] 杨鑫, 刘春莹. 鬼箭羽治疗糖尿病肾病药理机制的研究进展[J]. 中华老年多器官疾病杂志, 2023, 22(7): 557-560.
[34] 郝怿隆, 汪引芳, 黄亦童, 等. 中药提取物对细胞线粒体功能的影响及研究进展[J]. 医学综述, 2019, 25(9):1672-1676.
[35] 文晓晨, 王英, 刘若实, 等. 中药干预线粒体功能障碍治疗糖尿病肾病研究进展[J/OL]. 中国实验方剂学杂志, 1-14. 2025-08-03.[CrossRef
[36] 张金凤, 佟玉良, 王加朋, 等. 六味地黄丸对秀丽隐杆线虫AD模型线粒体损伤的保护作用[J]. 中国实验方剂学杂志, 2024, 30(3): 18-25.